Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001771317-20-000005
Filing Date
2020-10-21
Accepted
2020-10-21 20:26:34
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 5623
  Complete submission text file 0001771317-20-000005.txt   7088
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Issuer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11601 WILSHIRE BLVD. SUITE 1100 LOS ANGELES CA 90025
Business Address
Sherman Michael Edward (Reporting) CIK: 0001730468 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-39015 | Film No.: 201251431